January 03 , 2019 The Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001 GlaxoSmithKline Consumer Healthcare Ltd. 24-25 Fl oor, One Horizon Center Sector 43 , DLF Phase 5, Golf Cou rse Road Gurug ram (Harya na) , India - 122002 T +91 124 4336500 F +91 124 4336600 E [email protected]www.g sk.com The Listing Compliance Department National Stock Exchange of India Limited Exchange Plaza, C - 1, Block - G Bandra Kurla Complex, Bandra Mumbai - 400 051 Sub: Advance intimation under regulation 39(3) as SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir I Madam, Pursuant to Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the "Regulations"), we would like to inform you that Registrar and Transfer Agent of Company M/s. Karvy Fintech Private Limited has received below mentioned request for issue of duplicate Share Certificates from respective Shareholders: Sr.no. Name Folio no. Certificate no. Number Distinctive Distinctive of Shares no. From no. To 1. 58272 50 5140706 5140755 121436 50 7288843 7288892 Mahabir Gupta M04848 217286- 217287 100 26356979 26357078 383805- 383807 120 43006763 43006882 2. Shanta Anil Aartak S04153 233550- 233551 100 27586865 27586964 Anil Keshav Vartak 3. Shravan Sharma S02574 411399-411402 200 44227177 44227376 Padma Sharma 4, Nilaben Natverlal N00383 385896-385898 120 43086656 43086775 Amin We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s). We are enclosing the proof of the date of receipt of information by the Company Kindly take the same on record . Thanking You, For GlaxoSmithKline Consumer Healthcare Limited (Shanu Saksena) Company Secretary Encl.: as above CIN :L24231PB1958 PLC002257 Registered Office Patiala Ro ad Nabha (Punjab), India 147201
3
Embed
Sub: Advance intimation under regulation 39(3) as SEBI ... · Shanta Anil Aartak S04153 233550-233551 100 27586865 27586964 Anil Keshav Vartak 3. Shravan ... Dear Sir, Please see
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
January 03, 2019
The Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001
GlaxoSmithKline Consumer Healthcare Ltd. 24-25 Floor, One Horizon Center Sector 43, DLF Phase 5, Golf Course Road Gurugram (Haryana), India - 122002
The Listing Compliance Department National Stock Exchange of India Limited Exchange Plaza, C - 1, Block - G Bandra Kurla Complex, Bandra Mumbai - 400 051
Sub: Advance intimation under regulation 39(3) as SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Dear Sir I Madam,
Pursuant to Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the "Regulations"), we would like to inform you that Registrar and Transfer Agent of Company M/s. Karvy Fintech Private Limited has received below mentioned request for issue of duplicate Share Certificates from respective Shareholders:
Sr.no. Name Folio no. Certificate no. Number Distinctive Distinctive of Shares no. From no. To
We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the shareholder(s). We are enclosing the proof of the date of receipt of information by the Company
Kindly take the same on record .
Thanking You,
For GlaxoSmithKline Consumer Healthcare Limited
(Shanu Saksena) Company Secretary
Encl.: as above
C IN:L24231PB1958PLC002257 Registered Office Patiala Road Nabha (Punjab), India 147201
we are in receipt of request for issue of duplicate share certificates th~: details are as under
CODE INWARD NO FOLIO NAME INWARD DATE
M04848 MAHABIR GUPTA GXH 20038 31.12 .2018
GXH 20035 S04153 SHANTA ANIL VARTAK 31.12.2018
MR ANIL KESHAV VARTAK
Attached herewith soft copy request letter format of exchange notice.
Request you to kindly upload the same in exchange portals as per the new process
Regards
DAMODAR KEDLAYA ~ Dy. Manager I Corporate Registry
l(ARV V ll1 •·,~111·~1!1!!iilll!!#ll!llt1ll:•1
Karvy Fintech Private Limited (Formerly known as KCPL Advisory Services P Ltd) Karvy Selenium Tower B, Plot Nos. 31 & 32 I Financial District Nanakramguda I Serilingampally Manda I I Hyderabad - 500032 I India P : +91 040 67161511 [email protected]; I www.karvyfintech.com "Love all, serve all. Help ever, hurt never" oe This message (including any attachments) is intended only for the use ofthe individual or entity to which it is addressed and may contain information that is non-public, proprietary, privileged, confidential, and exempt from disclosure under applicable law or may constitute as attorney work product. If you are not the intended recipient, you are hereby notified that any use, dissemination, distribution, or copying of this communication is strictly prohibited. If you have received this communication in error, notify us immediately by telephone and (i) destroy this message if a facsimile or (ii) delete this message immediately if this is an electronic communication.
we are in receipt of request for issue of duplicate share certificates the details are as under
CODE INWARD NO FOLIO NAME INWARD DATE
GXH 20061 S02574 SHRAVAN SHARMA 02/01/2019
PADMA SHARMA NILABEN NATVERLAL
GXH 20064A N00383 AMIN 02/01/2019
Attached herewith soft copy request letter format of exchange notice.
Request you to kindly upload the same in exchange portals as per the new process
Regards
DAMODAR KEDLAYA ~ Dy. Manager I Corporate Registry
l<A RV V 111·• .. i"illl!lliil!!!l!ll!lill=·, Karvy Fintech Private Limited {Formerly known as KCPL Advisory Services P Ltd) Ka rvy Selen ium Tower B, Plot Nos. 31 & 32 I Financia l District Nanakramguda I Serilingampally Manda I I Hyderabad - 500032 I India P : +91 040 67161511 [email protected]; I www.ka rvyfintech.com "Love all, serve all. Help ever, hurt never"
,00 This message (including any attachments) is intended only for the use of the individual or entity to which it is addressed and may contain information that is non-public, proprietary, privileged, confidential, and exempt from disclosure under applicable law or may constitute as attorney work product. If you are not the intended recipient, you are hereby notified that any use, dissemination, distribution, or copying of this communication is strictly prohibited. If you have received this communication in error, notify us immediately by telephone and (i) destroy this message if a facsimile or (ii) delete this message immediately if this is an electronic communication .